Clinicn Investigator, Full Prf DOM ID Administration MGPO, Mass General Research Institute

PME OSE Chair, Honors in a Special Field Harvard Medical School

Professor of Medicine Harvard Medical School

Distinguished Physician Infectious Disease, Massachusetts General Hospital

MD Harvard Medical School 1990

anti-hiv agents; anti-retroviral agents; covid-19; hiv; hiv clinical trials; hiv-1; hiv/viral hepatitis coinfections

Rajesh T. Gandhi, MD, is Professor of Medicine at Harvard Medical School and Director of HIV Education at Massachusetts General Hospital (MGH). He is a leader in the NIH-funded AIDS Clinical Trials Group (ACTG), the world's largest HIV therapeutics clinical trials network (with sites in the US and around the world), and has chaired many clinical trials.  Dr. Gandhi is the Vice-Chair of the ACTG, as well as Chair of the network’s Scientific Agenda Steering Committee and clinical site leader of the MGH ACTG Clinical Research Site. Dr. Gandhi is also the Principal Investigator and Co-Director of the NIH-funded Harvard University Center for AIDS Research (CFAR). His research interests are in HIV reservoirs, HIV cure research, and HIV clinical trials. Dr. Gandhi is the editor of Infectious Disease Images, an educational infectious diseases website, and organizer of the HIV Online Provider Education (HOPE) program, an internet-based educational conference series for physicians caring for people with HIV in resource-limited settings. Dr. Gandhi is the Vice-Chair of the Infectious Diseases Society of America COVID-19 Treatment Guidelines Panel and Chair of the IAS USA Antiretroviral Treatment Guidelines Panel. He has written for NEJM Journal Watch Infectious Diseases since 2005 and served as Deputy Editor from 2016 until becoming Editor-in-Chief in 2023.

Dr. Gandhi received his medical degree from Harvard, completed his residency at the Brigham and Women's Hospital, and trained in infectious diseases at Johns Hopkins Hospital. His research interests include clinical trials of immune-based therapies for HIV, HIV reservoirs, and HIV/viral hepatitis coinfections.